ESC 365 - Predicting atrial fibrillation risk following embolic stroke of unknown source using cardiac magnetic resonance imaging

EHRA Premium Access

Predicting atrial fibrillation risk following embolic stroke of unknown source using cardiac magnetic resonance imaging

Session: Atrial fibrillation: stroke - oral anticoagulants

Topic: Stroke Treatment

Speaker: Doctor I. Kotadia (London, GB)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Irum Kotadia

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Genetic and clinical risk factors for stroke recurrence with different impact by assessment age: data from the UK Biobank

Speaker: Doctor S. Chung (Seoul, KR)

Direct oral anticoagulants versus vitamin K antagonists as stroke prevention in atrial fibrillation after cardiac surgery: a systematic review and meta-analysis

Speaker: Mr M. Terpstra (Amsterdam, NL)

Characteristics and incidence of peri-device leaks after left atrial appendage closure in patients with prior electrical isolation of left atrial appendage during catheter ablation

Speaker: Doctor A. Maan (New York, US)

Clinical impact of renal function changes in patients with atrial fibrillation receiving anticoagulation with marginal renal function

Speaker: Doctor K. Lee (Seoul, KR)

Impact of photoplethysmography-based smartphone rhythm monitoring on atrial fibrillation detection and management after cardiac surgery: a pragmatic randomized trial

Speaker: Doctor H. Gruwez (Genk, BE)

Access the full session

Atrial fibrillation: stroke - oral anticoagulants

Speakers: Doctor I. Kotadia, Doctor S. Chung, Mr M. Terpstra, Doctor A. Maan, Doctor K. Lee...

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources